Further analyses should be performed to determine whether these new splicing sites could impact the splicing of BRCA1 or BRCA2 mRNA, for example with minigene experiments, but the systematic analysis of non‐coding sequences of cancer‐predisposing genes could improve the efficiency of molecular diagnosis. This evidence concerns the gene BRCA2 and cancer.